Isobornylchalcones and flavones derived from them: synthesis and antioxidant activity
Methoxychalcones containing the NMe 2 , 3,4-(OMe) 2 , 3,4,5-(OMe) 3 , and isobornyl substituents in the B ring were synthesized from 1,3-dihydroxy-4-(1,7,7-trimethylbicyclo-[2.2.1]hept- exo -2-yl)benzene and 1,4-dihydroxy-3-(1,7,7-trimethylbicyclo[2.2.1]hept- exo -2-yl)benzene. Oxidative cyclization...
Saved in:
Published in | Russian chemical bulletin Vol. 73; no. 6; pp. 1775 - 1788 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.06.2024
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Methoxychalcones containing the NMe
2
, 3,4-(OMe)
2
, 3,4,5-(OMe)
3
, and isobornyl substituents in the B ring were synthesized from 1,3-dihydroxy-4-(1,7,7-trimethylbicyclo-[2.2.1]hept-
exo
-2-yl)benzene and 1,4-dihydroxy-3-(1,7,7-trimethylbicyclo[2.2.1]hept-
exo
-2-yl)benzene. Oxidative cyclization of the new isobornylchalcones afforded flavones bearing the 1,7,7-trimethylbicyclo[2.2.1]hept-
exo
-2-yl moiety. The erythrotoxicity, membrane-protective, and antioxidant activity of the synthesized compounds were evaluated in
in vitro
models including the model of oxidative hemolysis of mammalian erythrocytes initiated by H
2
O
2
or 2,2′-azobis-(2-amidinopropane) dihydrochloride. All the chalcones studied and most flavones possessed good hemocompatibility and high antioxidant activity. The promise of further research into the synthesis of effective pharmacological substances based on the title compounds was demonstrated. |
---|---|
ISSN: | 1066-5285 1573-9171 |
DOI: | 10.1007/s11172-024-4295-6 |